Print

Ligand Pharmaceuticals Inc. (LGND) To Participate In ROTH Capital Partners’ Healthcare Corporate Access Day In London  
6/24/2014 8:42:20 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) today announced that it will participate in the ROTH Capital Partners’ Healthcare Corporate Access Day to be held on Tuesday, June 24, 2014 in London. The event features one-on-one and small-group meetings with institutional investors, primarily from the U.K. and Europe. An updated corporate presentation used by management at the event will be available on Tuesday, June 24, 2014 at www.ligand.com.

Help employers find you! Check out all the jobs and post your resume.

//-->